1 / 5

Europe Influenza Market Size, Scope 2022-2028

The europe influenza market size was valued at USD 2.6 billion in 2021 and is poised to grow at a significant CAGR of 9.5% during the forecast period 2022-28. Influenza, commonly referred to as the flu, is a viral infection that occurs in the respiratory system. Type A, Type B, and Type C are the three main influenza viruses that affect humans. The fourth influenza virus, classified as Type D, does not infect people, although it is thought to have the capacity to do so in the future. Coughing, sore throat, runny nose, migraine, sneezing, chest infection, joint aches, and fatigue are all freque

rekha8
Download Presentation

Europe Influenza Market Size, Scope 2022-2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Europe Influenza Market-2022-2028 1

  2. Market Overview: The europe influenza market size was valued at USD 2.6 billion in 2021 and is poised to grow at a significant CAGR of 9.5% during the forecast period 2022-28. The Europe Influenza Market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the Europe Influenza Market analysis from 2022 to 2028 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

  3. Market Segments: The Europe Influenza Market has been fragmented based on: 1. By Drug Class: Anti-viral drugs, Interferons, Vaccines 2. By Route Of Administration: Oral, Parenteral, Others 3. By Country: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America Request Sample Report 3

  4. Key Players: Some of the major key players in the Europe Influenza Market are: •AstraZeneca (U.K.) •F. Hoffmann-La Roche (Switzerland) •GlaxoSmithKline Plc. (U.K.) •Novartis AG (Switzerland) •Sanofi (France) Request Sample Report 4

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5

More Related